Zymeworks

Index
Globenewswire

Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results

Globenewswire

Zymeworks Announces Participation in Upcoming Investor Conferences...

Globenewswire

Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors

Globenewswire

Zymeworks Announces Participation in Upcoming Investor Conferences..

Globenewswire

Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting

Globenewswire

Zymeworks Announces Participation in Upcoming Investor Conferences.

Globenewswire

Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors

Globenewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

Globenewswire

Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025

Globenewswire

Zymeworks Announces Additional Leadership Appointments

Globenewswire

Zymeworks Announces $50 Million Private Placement to EcoR1 Capital

Globenewswire

Zymeworks Added to Nasdaq Biotechnology Index

Globenewswire

Zymeworks Announces Participation in Upcoming Investor Conference